147 related articles for article (PubMed ID: 12082110)
1. A novel antithrombotic role for high molecular weight kininogen as inhibitor of plasminogen activator inhibitor-1 function.
Chavakis T; Pixley RA; Isordia-Salas I; Colman RW; Preissner KT
J Biol Chem; 2002 Sep; 277(36):32677-82. PubMed ID: 12082110
[TBL] [Abstract][Full Text] [Related]
2. Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions.
Chavakis T; Kanse SM; Lupu F; Hammes HP; Müller-Esterl W; Pixley RA; Colman RW; Preissner KT
Blood; 2000 Jul; 96(2):514-22. PubMed ID: 10887113
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of platelet adhesion and aggregation by a defined region (Gly-486-Lys-502) of high molecular weight kininogen.
Chavakis T; Boeckel N; Santoso S; Voss R; Isordia-Salas I; Pixley RA; Morgenstern E; Colman RW; Preissner KT
J Biol Chem; 2002 Jun; 277(26):23157-64. PubMed ID: 11970955
[TBL] [Abstract][Full Text] [Related]
4. Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation.
Kost C; Stüber W; Ehrlich HJ; Pannekoek H; Preissner KT
J Biol Chem; 1992 Jun; 267(17):12098-105. PubMed ID: 1376317
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis in vascular cells by plasminogen activator inhibitor-1 and high molecular weight kininogen correlates with their anti-adhesive properties.
Al-Fakhri N; Chavakis T; Schmidt-Wöll T; Huang B; Cherian SM; Bobryshev YV; Lord RS; Katz N; Preissner KT
Biol Chem; 2003 Mar; 384(3):423-35. PubMed ID: 12715893
[TBL] [Abstract][Full Text] [Related]
6. The urokinase receptor is a major vitronectin-binding protein on endothelial cells.
Kanse SM; Kost C; Wilhelm OG; Andreasen PA; Preissner KT
Exp Cell Res; 1996 May; 224(2):344-53. PubMed ID: 8612711
[TBL] [Abstract][Full Text] [Related]
7. Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin.
Preissner KT; Grulich-Henn J; Ehrlich HJ; Declerck P; Justus C; Collen D; Pannekoek H; Müller-Berghaus G
J Biol Chem; 1990 Oct; 265(30):18490-8. PubMed ID: 1698787
[TBL] [Abstract][Full Text] [Related]
8. Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface.
Podor TJ; Singh D; Chindemi P; Foulon DM; McKelvie R; Weitz JI; Austin R; Boudreau G; Davies R
J Biol Chem; 2002 Mar; 277(9):7529-39. PubMed ID: 11744725
[TBL] [Abstract][Full Text] [Related]
9. Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin (Vn): mapping the binding sites on PAI-1 and Vn.
Schroeck F; Arroyo de Prada N; Sperl S; Schmitt M; Viktor M
Biol Chem; 2002; 383(7-8):1143-9. PubMed ID: 12437099
[TBL] [Abstract][Full Text] [Related]
10. Type 1 plasminogen activator inhibitor binds to fibrin via vitronectin.
Podor TJ; Peterson CB; Lawrence DA; Stefansson S; Shaughnessy SG; Foulon DM; Butcher M; Weitz JI
J Biol Chem; 2000 Jun; 275(26):19788-94. PubMed ID: 10764803
[TBL] [Abstract][Full Text] [Related]
11. Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin.
Arroyo De Prada N; Schroeck F; Sinner EK; Muehlenweg B; Twellmeyer J; Sperl S; Wilhelm OG; Schmitt M; Magdolen V
Eur J Biochem; 2002 Jan; 269(1):184-92. PubMed ID: 11784312
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the binding of different conformational forms of plasminogen activator inhibitor-1 to vitronectin. Implications for the regulation of pericellular proteolysis.
Lawrence DA; Palaniappan S; Stefansson S; Olson ST; Francis-Chmura AM; Shore JD; Ginsburg D
J Biol Chem; 1997 Mar; 272(12):7676-80. PubMed ID: 9065424
[TBL] [Abstract][Full Text] [Related]
13. The somatomedin B domain of vitronectin. Structural requirements for the binding and stabilization of active type 1 plasminogen activator inhibitor.
Seiffert D; Ciambrone G; Wagner NV; Binder BR; Loskutoff DJ
J Biol Chem; 1994 Jan; 269(4):2659-66. PubMed ID: 7507927
[TBL] [Abstract][Full Text] [Related]
14. Wound-induced migration of MDA-MB-435 and SKOV-3 cancer cells is regulated by plasminogen activator inhibitor-1.
Whitley BR; Church FC
Int J Oncol; 2005 Sep; 27(3):749-57. PubMed ID: 16077925
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor type-1 inhibits insulin signaling by competing with alphavbeta3 integrin for vitronectin binding.
López-Alemany R; Redondo JM; Nagamine Y; Muñoz-Cánoves P
Eur J Biochem; 2003 Mar; 270(5):814-21. PubMed ID: 12603314
[TBL] [Abstract][Full Text] [Related]
16. Identification of the plasminogen activator inhibitor-1 binding heptapeptide in vitronectin.
Mimuro J; Muramatsu S; Kurano Y; Uchida Y; Ikadai H; Watanabe S; Sakata Y
Biochemistry; 1993 Mar; 32(9):2314-20. PubMed ID: 7680229
[TBL] [Abstract][Full Text] [Related]
17. Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?
Deng G; Curriden SA; Wang S; Rosenberg S; Loskutoff DJ
J Cell Biol; 1996 Sep; 134(6):1563-71. PubMed ID: 8830783
[TBL] [Abstract][Full Text] [Related]
18. Intra- and extracellular plasminogen activator inhibitor-1 regulate effect of vitronectin against radiation-induced endothelial cell death.
Hazawa M; Yasuda T; Saotome-Nakamura A; Tomiyama K; Obara C; Goto T; Tajima K
Vascul Pharmacol; 2016 Dec; 87():150-158. PubMed ID: 27650166
[TBL] [Abstract][Full Text] [Related]
19. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
[TBL] [Abstract][Full Text] [Related]
20. Truncated vitronectins: binding to immobilized fibrin and to fibrin clots, and their subsequent interaction with cells.
Schvartz I; Seger D; Maik-Rachline G; Kreizman T; Shaltiel S
Biochem Biophys Res Commun; 2002 Jan; 290(2):682-9. PubMed ID: 11785953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]